Interlinked Therapeutics

The submission for Interlinked Therapeutics lacks substantial detail and contains highly unrealistic statements (e.g., 'most people have used my product'). Despite machine learning drug discovery being a relevant field with high utility, the project provides no verifiable user metrics, no technical specifics, and a confusing market cap claim without adequate context. Consequently, the quality multipliers across all criteria reflect the vague and unsupported nature of the claims.